Repeated local implantation of autologous peripheral blood mononuclear cells for the treatment of ischaemic digits in patients with connective tissue diseases

Rheumatology

Volumn 50, Issue 5, 2011, Pages 906-910

  Kamata, Yasuyuki ^a   Iwamoto, Masahiro ^a   Muroi, Kazuo ^a   Minota, Seiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Connective tissue disease; Implantation; Peripheral blood mononuclear cells

Indexed keywords

ENDOSTATIN; FIBROBLAST GROWTH FACTOR; INTERLEUKIN 1BETA; PREDNISOLONE; VASCULOTROPIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE DISEASE; DIGITAL SUBTRACTION ANGIOGRAPHY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FINGER BLOOD FLOW; FOLLOW UP; HUMAN; MALE; MICROSCOPIC POLYANGIITIS; PATIENT SATISFACTION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; SAFETY; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

AGED; FIBROBLAST GROWTH FACTORS; FINGERS; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-1BETA; ISCHEMIA; LEUKOCYTES, MONONUCLEAR; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; PAIN MEASUREMENT; PATIENT SATISFACTION; REGIONAL BLOOD FLOW; TOES; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79955134178     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq389     Document Type: Article

References (13)

1. Smith CD, McKendry RJ. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon. Lancet 1982;11: 1299-301.
2. Langevitz P, Buskila D, Lee P, Urowitz MB. Treatment of refractory ischemic skin ulcers in patients with Raynaud's phenomenon with PGE1 infusions. J Rheumatol 1989;16: 1433-5.
3. Kirby JD, Lima DR, Dowd PM, Kilfeather S, Turner P. Prostacyclin increases cyclic-nucleotide responsiveness of lymphocytes from patients with systemic sclerosis. Lancet 1980;30:453-4.
4. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;14:964-7.
5. Tateishi-Yuyama E, Matsubara H, Murohara T et al. Therapeutic Angiogenesis using Cell Transplantation (TACT) study investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet 2002;360:427-35.
6. Kamata Y, Takahashi Y, Iwamoto M et al. Local implantation of autologous mononuclear cells from bone marrow and peripheral blood for treatment of ischaemic digits in patients with connective tissue diseases. Rheumatology 2007;46:882-4.
7. Ferrante A, Thong YH. Optimal conditions for simultaneous purification of mononuclear and polymorphonuclear leucocytes from human blood by the Hypaque-Ficoll method. J Immunol Methods 1980;36: 109-17.
8. Burt RK, Fassas A, Snowden J et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 2001;28:1-12.
9. Fleming JN, Nash RA, McLeod DO et al. Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS One 2008;16:e1452.
10. Ytterberg SR, Schnitzer TJ. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 1982;25:401-6.
11. Singh RK, Gutman M, Bucana CD, Sanchez R, Llansa N, Fidler IJ. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 1995;92: 4562-6.
12. Black CM, Silman AJ, Herrick AI et al. Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1999;42:299-305.
13. Denny MF, Thacker S, Mehta H et al. Interferon-alpha promotes abnomal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 2007;110: 2907-15.